Chemoinformaics analysis of DIHYDRO-BETA-IONOL
| Molecular Weight | 196.334 | nRot | 3 |
| Heavy Atom Molecular Weight | 172.142 | nRig | 6 |
| Exact Molecular Weight | 196.183 | nRing | 1 |
| Solubility: LogS | -3.295 | nHRing | 0 |
| Solubility: LogP | 3.671 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 38 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 38.515 |
| nHD | 1 | BPOL | 24.077 |
| QED | 0.683 |
| Synth | 3.213 |
| Natural Product Likeliness | 2.06 |
| NR-PPAR-gamma | 0.248 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.111 |
| Pgp-sub | 0.005 |
| HIA | 0.003 |
| CACO-2 | -4.469 |
| MDCK | 0.0000182 |
| BBB | 0.786 |
| PPB | 0.950081 |
| VDSS | 2.677 |
| FU | 0.0355297 |
| CYP1A2-inh | 0.344 |
| CYP1A2-sub | 0.805 |
| CYP2c19-inh | 0.258 |
| CYP2c19-sub | 0.883 |
| CYP2c9-inh | 0.119 |
| CYP2c9-sub | 0.919 |
| CYP2d6-inh | 0.021 |
| CYP2d6-sub | 0.699 |
| CYP3a4-inh | 0.031 |
| CYP3a4-sub | 0.22 |
| CL | 10.597 |
| T12 | 0.238 |
| hERG | 0.007 |
| Ames | 0.008 |
| ROA | 0.022 |
| SkinSen | 0.135 |
| Carcinogencity | 0.082 |
| EI | 0.954 |
| Respiratory | 0.164 |
| NR-Aromatase | 0.015 |
| Antiviral | Yes |
| Prediction | 0.760561 |